This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McHardy, L. M. Articles by Roskelley, C. D. Search for Related Content PubMed PubMed Citation Articles by McHardy, L. M. Articles by Roskelley, C. D.

The Tumor Invasion Inhibitor Dihydromotuporamine C Activates RHO, Remodels Stress Fibers and Focal Adhesions, and Stimulates Sodium–Proton Exchange

Departments of¹ Biochemistry and Molecular Biology, ² Anatomy and Cell Biology, and ³ Chemistry and Earth and Ocean Sciences at the University of British Columbia, and the ⁴ Jack Bell Research Laboratories at the B.C. Cancer Agency, Vancouver, British Columbia, Canada

The motuporamines are macrocyclic alkaloids that inhibit tumor cell invasion by an, as yet, unknown mechanism. A structure–activity study recently identified dihydromotuporamine C (dhMotC) as a highly active and readily synthesized analogue. Here, we show that dhMotC causes subtle cytoskeletal alterations in highly invasive MDA231 breast tumor cells that include an increase in the thickness and number of cytoplasmic actin stress fibers. Experiments with serum-starved Swiss 3T3 fibroblasts showed that micromolar concentrations of dhMotC that inhibit tumor cell invasion induce the formation of new stress fibers and large focal adhesion complexes that are dispersed around the entire cell periphery. dhMotC treatment of Swiss 3T3 cells also initiates a strong, long-lived activation of the small GTP-binding protein Rho, and it stimulates Rho kinase-dependent sodium–proton exchanger activity. Liposome-mediated cell loading of C3 exoenzyme prevents dhMotC-mediated Rho activation and stress fiber formation in 3T3 cells. C3 exoenzyme loading also reestablishes elongated MDA231 breast tumor cell invasion in the presence of dhMotC. Taken together, these results indicate that the ability to activate Rho is one important determinant of the anti-invasive activity of dhMotC.

This article has been cited by other articles:

				M. Roberge Defining Drug Targets in Yeast Haploinsufficiency Screens: Application to Human Translational Pharmacology Sci. Signal., August 26, 2008; 1(34): pt5 - pt5. [Abstract] [Full Text] [PDF]

				R. A. Cardone, A. Bellizzi, G. Busco, E. J. Weinman, M. E. Dell'Aquila, V. Casavola, A. Azzariti, A. Mangia, A. Paradiso, and S. J. Reshkin The NHERF1 PDZ2 Domain Regulates PKA-RhoA-p38-mediated NHE1 Activation and Invasion in Breast Tumor Cells Mol. Biol. Cell, May 1, 2007; 18(5): 1768 - 1780. [Abstract] [Full Text] [PDF]

				R. A. Cardone, A. Bagorda, A. Bellizzi, G. Busco, L. Guerra, A. Paradiso, V. Casavola, M. Zaccolo, and S. J. Reshkin Protein Kinase A Gating of a Pseudopodial-located RhoA/ROCK/p38/NHE1 Signal Module Regulates Invasion in Breast Cancer Cell Lines Mol. Biol. Cell, July 1, 2005; 16(7): 3117 - 3127. [Abstract] [Full Text] [PDF]

				L. M. McHardy, K. Warabi, R. J. Andersen, C. D. Roskelley, and M. Roberge Strongylophorine-26, a Rho-dependent inhibitor of tumor cell invasion that reduces actin stress fibers and induces nonpolarized lamellipodial extensions Mol. Cancer Ther., May 1, 2005; 4(5): 772 - 778. [Abstract] [Full Text] [PDF]

				Q.-Y. Lu, Y.-S. Jin, A. Pantuck, Z.-F. Zhang, D. Heber, A. Belldegrun, M. Brooks, R. Figlin, and J. Rao Green Tea Extract Modulates Actin Remodeling via Rho Activity in an In vitro Multistep Carcinogenic Model Clin. Cancer Res., February 15, 2005; 11(4): 1675 - 1683. [Abstract] [Full Text] [PDF]